Form 4: Indaptus Therapeutics CEO Cancels Stock Options, Receives $500 Consideration
SEC Form 4
CEO Jeffrey Meckler reports the cancellation of several stock option grants by mutual agreement with Indaptus Therapeutics, receiving $500 in consideration.
Summary
- Jeffrey A. Meckler, CEO of Indaptus Therapeutics, reported the cancellation of multiple stock option grants on April 10, 2025.
- The cancellations were by mutual agreement between Meckler and Indaptus Therapeutics.
- Meckler received a total of $500 as consideration for the cancellation of the options.
- The options, which had various exercise prices and expiration dates, were all related to Indaptus Therapeutics common stock.
- Following the reported transaction, Meckler's holdings of these specific derivative securities are now zero.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a transaction (cancellation of stock options) without indicating positive or negative performance.
Key Dates
| Date | Description |
|---|---|
| 12/11/2017 | Original grant date of one of the canceled stock option grants. |
| 05/01/2017 | Original grant date of one of the canceled stock option grants. |
| 06/28/2018 | Original grant date of one of the canceled stock option grants. |
| 04/04/2019 | Original grant date of one of the canceled stock option grants. |
| 07/15/2020 | Original grant date of one of the canceled stock option grants. |
| 04/10/2025 | Date of the stock option cancellations. |
| 04/11/2025 | Date of signature on the Form 4 filing. |
| 04/10/2027 | Original expiration date of one of the canceled stock option grants. |
| 05/01/2027 | Original expiration date of one of the canceled stock option grants. |
| 06/28/2025 | Original expiration date of one of the canceled stock option grants. |
| 07/15/2027 | Original expiration date of one of the canceled stock option grants. |
| 12/11/2027 | Original expiration date of one of the canceled stock option grants. |
Keywords
stock options, Indaptus Therapeutics, CEO, Jeffrey Meckler, cancellation, Form 4, INDP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.